Galderma Canada Inc. et al. v Sandoz Canada Inc.
2020
T-886-20
Pending
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent Nos. 2,440,472, 2,521,885, and 2,803,922 (doxycycline)
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team
Warren Sprigings
Partner
Mingquan Zhang, Ph.D.
Associate